Your browser doesn't support javascript.
loading
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Chen, Jianfeng; Hong, Jing Han; Huang, Yulin; Liu, Shini; Yin, Jiaxin; Deng, Peng; Sun, Yichen; Yu, Zhaoliang; Zeng, Xian; Xiao, Rong; Chan, Jason Yongsheng; Guan, Peiyong; Wang, Yali; Wang, Peili; Liu, Lizhen; Wen, Shijun; Yu, Qiang; Ong, Choon Kiat; Teh, Bin-Tean; Xiong, Ying; Tan, Jing.
Afiliação
  • Chen J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China. chenjf@sysucc.org.cn.
  • Hong JH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, Guangdong, 510060, P. R. China. chenjf@sysucc.org.cn.
  • Huang Y; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
  • Liu S; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Yin J; Department of Oncology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong, 510060, P. R. China.
  • Deng P; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Sun Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Yu Z; Department of Laboratory Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangdong, 510060, P. R. China.
  • Zeng X; Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510655, P. R. China.
  • Xiao R; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Chan JY; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Guan P; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • Wang Y; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
  • Wang P; Genome Institute of Singapore, A*STAR, Singapore, Singapore.
  • Liu L; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Wen S; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Yu Q; Center of Medical Research, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong, 510060, P. R. China.
  • Ong CK; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Teh BT; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
  • Xiong Y; Genome Institute of Singapore, A*STAR, Singapore, Singapore.
  • Tan J; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
Mol Cancer ; 22(1): 85, 2023 05 20.
Article em En | MEDLINE | ID: mdl-37210576

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína Potenciadora do Homólogo 2 de Zeste Limite: Female / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína Potenciadora do Homólogo 2 de Zeste Limite: Female / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article